Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Cyclacel Pharmaceuticals First Quarter 2023 Results Conference Call and Webcast.
Posts Tagged ‘NASDAQ:CYCC’
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q4 2022 Earnings Call Transcript
Operator: Good afternoon and welcome to the Cyclacel Pharmaceuticals Fourth Quarter and Full Year 2022 Results Conference Call and Webcast.
10 Popular Penny Stocks on Robinhood
According to the letter acquired by CNBC from Citadel Securities' Institutional Equity Derivatives team, stocks selling below $1 per share recorded an average gain of roughly ...
Hedge Funds Have Never Been This Bullish On Cyclacel Pharmaceuticals Inc (CYCC)
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...
5 Underperforming Stocks Targeted By Short Sellers
In this article we discuss top 5 underperforming stocks targeted by short sellers.
13D Filing: Tang Capital Partners LP and Cyclacel Pharmaceuticals Inc. (CYCC)
Please follow Tang Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Tang Capital Management or update its...
Why Cyclacel Pharmaceuticals Inc (CYCC) is in the Spotlight
Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) shares have popped over 30% this afternoon due to momentum traders buying the stock for technical reasons.
Here’s What Is Happening In Financial Markets Today?
“Wall Street stocks on Monday were aiming to start the second quarter with tepid gains.
Here’s What Happened With Cyclacel Pharmaceuticals Inc (CYCC) And Nivalis Therapeutics Inc (NVLS)
This week was a good one for a few biotechs, but not so great for others.
Here’s Why Cyclacel Pharmaceuticals Inc (CYCC) Could Have A Rough December
Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) soared throughout the US session on Thursday, gaining as much as 60% across the day.
Movers and Shakers In Biotech: Cyclacel Pharmaceuticals Inc (CYCC) and Corium International Inc (CORI)
Yet again, we’ve had a busy start to the week in biotech.
Why Are Traders Piling Into These Stocks?
Crude futures are up more than 2% this morning as weakness in the dollar and supply disturbances boost sentiment.
ACADIA Pharmaceuticals Inc. (ACAD), Pfizer Inc. (PFE): Sabby Management Rewarded for Its Healthcare Picks
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) spiked nearly 18% during Tuesday's intraday trading and hit a 52-week high of $46.48.
Tang Capital Management Is Getting Out of OncoGenex Pharmaceuticals Inc (OGXI) and Cyclacel Pharmaceuticals Inc (CYCC)
Kevin C. Tang's Tang Capital Management has decreased its position it two pharmaceutical companies.
Jeremy Green, Redmile Group Drop Cyclacel Pharmaceuticals Like It’s Hot
Jeremy Green, Redmile Group: In a passive 13G filing with the SEC just now, the San Francisco-based Redmile Group, managed by Jeremy Green, has closed out its position in Cyclacel...
Hedge Funds Are Selling Affymax, Inc. (AFFY) – Northwest Biotherapeutics, Inc (NWBO), Celsion Corporation (CLSN)
In today’s marketplace, there are many metrics investors can use to watch Mr. Market. A couple of the most under-the-radar are hedge fund and insider trading interest.
